US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Argentina and Global Exposure ETF

26.38

0.0000

Volume:- -

Turnover:- -

Market Cap:5.28M

PE:- -

High:26.38

Open:26.38

Low:26.38

Close:26.38

52wk High:31.89

52wk Low:19.95

Shares:200.00K

Float Shares:200.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

Press Release: Enbridge Reports Strong Third Quarter Results, Announces Accretive Investments and Reaffirms 2025 Financial Guidance

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AGT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGT\",,,,,undefined,":{"symbol":"AGT","market":"US","secType":"STK","nameCN":"iShares MSCI Argentina and Global Exposure ETF","latestPrice":26.38,"timestamp":1662148800000,"preClose":26.38,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"09-02 16:00:00 EDT","open":26.38,"high":26.38,"low":26.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":26.38,"sharesOutstanding":200000,"nav":26.4147,"aum":5283411.86,"bidAskSpread":0.002165,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGT\",,,,,undefined,":{"symbol":"AGT","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"shares":200000,"dividePrice":0,"high":26.38,"amplitude":0,"preClose":26.38,"low":26.38,"week52Low":19.95,"pbRate":"--","week52High":31.89,"institutionHeld":0,"latestPrice":26.38,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":26.38,"prevYearClose":26.8655},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-23","symbol":"AGT","reason":null,"defaultRemindTime":1661261400000,"announcedDate":"2022-06-27","type":"delisting","dateTimestamp":1661227200000},{"market":"US","date":"2022-06-09","symbol":"AGT","amount":0.414912,"defaultRemindTime":1654781400000,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2022-06-15","payableDate":"2022-06-10","currency":"USD","type":"dividend","dateTimestamp":1654747200000},{"market":"US","date":"2021-12-13","symbol":"AGT","amount":0.233806,"defaultRemindTime":1639405800000,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2021-12-17","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2021-06-10","symbol":"AGT","amount":0.044975,"defaultRemindTime":1623331800000,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2021-06-16","payableDate":"2021-06-11","currency":"USD","type":"dividend","dateTimestamp":1623297600000},{"market":"US","date":"2020-12-14","symbol":"AGT","amount":0.171053,"name":"iShares MSCI Argentina and Global Exposure ETF","recordDate":"2020-12-18","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGT\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.203547,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":0.023372,"currency":"USD"},{"executeDate":"2019-06-17","recordDate":"2019-06-18","paymentDate":"2019-06-21","value":0.223864,"currency":"USD"},{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.081776,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.063899,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602543576","title":"CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543576","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543576?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224960,"startTime":"0","endTime":"0","summary":"-2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216929/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and-Anticipated-2026-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","SLE","LU2237438978.USD","LU0251131958.USD","BK4149","LU0742534661.SGD","BK4153","BK4077","AGT","BK4090","LU0868494617.USD","CRSP","TG","BK4022","LU1720051108.HKD","LU2357305700.SGD","LU0963586101.USD","LU0942090050.USD","CAR","LU1917777945.USD","SCD","BK4199","IE00BSNM7G36.USD","LU0251142724.SGD","BK4532","LU1974910355.USD","LU2264538146.SGD","LU2106854487.HKD","LU1861559042.SGD","LU0868494708.USD","CAT","FXI","BK4520","BK4588","BK4556","BK4597","LU1064131342.USD","BK4611","BK4230","LU1861558580.USD","ITP","IE00BD6J9T35.USD","LU0048573561.USD","BK4516","LU1548497426.USD","LU2023250504.SGD","LU1988902786.USD","LDL","BK4504","BK4139"],"gpt_icon":0},{"id":"2581007832","title":"Press Release: Enbridge Reports Strong Third Quarter Results, Announces Accretive Investments and Reaffirms 2025 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581007832","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581007832?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:00","pubTimestamp":1762516800,"startTime":"0","endTime":"0","summary":"CALGARY, AB, Nov. 7, 2025 /PRNewswire/ - Enbridge Inc.    today reported third quarter 2025 financial results, reaffirmed its 2025 financial guidance and provided a quarterly business update.-- Third quarter GAAP earnings attributable to common shareholders of $0.7. billion or $0.30 per common share, compared with GAAP earnings. attributable to common shareholders of $1.3 billion or $0.59 per common. -- Adjusted earnings* of $1.0 billion or $0.46 per common share*, compared. with $1.2 billion or $0.55 per common share in 2024. -- Adjusted earnings before interest, income taxes and depreciation and. amortization * of $4.3 billion, compared with $4.2 billion in. -- Cash provided by operating activities of $2.9 billion, compared with $3.0. IL, creating 100 kbpd of long-haul, contracted service to Nederland, TX. via a 30 kbpd expansion on Express-Platte and utilizing 70 kbpd of. -- Exited the quarter with Debt-to-EBITDA* of 4.8x. \"Energy demand continues to grow in North America and beyond","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2237443622.USD","BK4588","LU2237443382.USD","LU2237443978.SGD","BK4144","IE00B3CCJ963.GBP","DCF","ENB","IE00B2Q91V27.USD","IE00BGHQF524.EUR","LU0238689110.USD","AGT","LU2237443549.SGD"],"gpt_icon":0},{"id":"2566648763","title":"CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2566648763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566648763?lang=en_us&edition=fundamental","pubTime":"2025-09-10 04:00","pubTimestamp":1757448000,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Sept.  09, 2025  (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/09/3147319/0/en/CRISPR-Therapeutics-to-Present-Late-Breaking-Data-at-the-American-Heart-Association-AHA-Scientific-Sessions-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4585","LU1861559042.SGD","AFG","BK4588","BK4117","CRSP","BK4556","BK4007","LENZ","LU1861558580.USD","BK4539","AHP","BK4611","BK4139","AGT"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AGT\",params:#limit:6,delay:false,,,undefined,":[]}}